A Multicenter, Phase Ii Study Of Trastuzumab Plus Capecitabine And Oxaliplatin (Xelox) As First-Line Chemotherapy For Her2-Positive Advanced Gastric Cancer: Update Results Of Efficacy And Toxicity.
JOURNAL OF CLINICAL ONCOLOGY（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要